Management of cardiovascular concerns during the pandemic

SARS-CoV-2, known as COVID-19, brought the world to a screeching halt nearly two and a half years ago. The emergent global collaboration resulted in enhanced understanding of the disease, fast-paced production of molecular and antibody-based assays to assist in management and finally, 10 different vaccines (Emergency Use Listing, WHO) to enable prevention.

This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.

Existing Users Log In